Loading...
| A04506 | Pages: NA | Dec 2021 | 1273 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4 COLON CANCER DIAGNOSTIC TESTS MARKET, BY TEST
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. FECAL OCCULT BLOOD TESTS (FOBT)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Guaiac FOB stool test
4.2.4.1. Market size and forecast
4.2.5. Immuno-FOB ELISA test
4.2.5.1. Market size and forecast
4.3. BIOMARKER TESTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. DNA based biomarkers test
4.3.4.1. Market size and forecast
4.3.5. Protein based biomarkers test
4.3.5.1. Market size and forecast
4.3.6. Metabolite based biomarkers test
4.3.6.1. Market size and forecast
CHAPTER 5 COLON CANCER DIAGNOSTIC TESTS MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Market size and forecast
5.3. CLINICAL DIAGNOSTIC LABORATORIES
5.3.1. Market size and forecast
5.4. PHYSICIANS’ OFFICE LABORATORIES
5.4.1. Market size and forecast
5.5. HOME TEST KIT
5.5.1. Market size and forecast
CHAPTER 6 COLON CANCER DIAGNOSTIC TESTS MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. North America Colon Cancer Diagnostic Tests Market by Country
6.2.3.1. U.S.
6.2.3.1.1. U.S. Colon Cancer Diagnostic Tests Market by Test
6.2.3.1.2. U.S. Colon Cancer Diagnostic Tests Market by End User
6.2.3.2. Canada
6.2.3.2.1. Canada Colon Cancer Diagnostic Tests Market by Test
6.2.3.2.2. Canada Colon Cancer Diagnostic Tests Market by End User
6.2.3.3. Mexico
6.2.3.3.1. Mexico Colon Cancer Diagnostic Tests Market by Test
6.2.3.3.2. Mexico Colon Cancer Diagnostic Tests Market by End User
6.2.4. North America Colon Cancer Diagnostic Tests Market by Test
6.2.5. North America Colon Cancer Diagnostic Tests Market by End User
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Europe Colon Cancer Diagnostic Tests Market by Country
6.3.3.1. Germany
6.3.3.1.1. Germany Colon Cancer Diagnostic Tests Market by Test
6.3.3.1.2. Germany Colon Cancer Diagnostic Tests Market by End User
6.3.3.2. France
6.3.3.2.1. France Colon Cancer Diagnostic Tests Market by Test
6.3.3.2.2. France Colon Cancer Diagnostic Tests Market by End User
6.3.3.3. UK
6.3.3.3.1. UK Colon Cancer Diagnostic Tests Market by Test
6.3.3.3.2. UK Colon Cancer Diagnostic Tests Market by End User
6.3.3.4. Italy
6.3.3.4.1. Italy Colon Cancer Diagnostic Tests Market by Test
6.3.3.4.2. Italy Colon Cancer Diagnostic Tests Market by End User
6.3.3.5. Spain
6.3.3.5.1. Spain Colon Cancer Diagnostic Tests Market by Test
6.3.3.5.2. Spain Colon Cancer Diagnostic Tests Market by End User
6.3.3.6. Rest of Europe
6.3.3.6.1. Rest of Europe Colon Cancer Diagnostic Tests Market by Test
6.3.3.6.2. Rest of Europe Colon Cancer Diagnostic Tests Market by End User
6.3.4. Europe Colon Cancer Diagnostic Tests Market by Test
6.3.5. Europe Colon Cancer Diagnostic Tests Market by End User
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Asia-Pacific Colon Cancer Diagnostic Tests Market by Country
6.4.3.1. Japan
6.4.3.1.1. Japan Colon Cancer Diagnostic Tests Market by Test
6.4.3.1.2. Japan Colon Cancer Diagnostic Tests Market by End User
6.4.3.2. China
6.4.3.2.1. China Colon Cancer Diagnostic Tests Market by Test
6.4.3.2.2. China Colon Cancer Diagnostic Tests Market by End User
6.4.3.3. Australia
6.4.3.3.1. Australia Colon Cancer Diagnostic Tests Market by Test
6.4.3.3.2. Australia Colon Cancer Diagnostic Tests Market by End User
6.4.3.4. India
6.4.3.4.1. India Colon Cancer Diagnostic Tests Market by Test
6.4.3.4.2. India Colon Cancer Diagnostic Tests Market by End User
6.4.3.5. South Korea
6.4.3.5.1. South Korea Colon Cancer Diagnostic Tests Market by Test
6.4.3.5.2. South Korea Colon Cancer Diagnostic Tests Market by End User
6.4.3.6. Rest of Asia-Pacific
6.4.3.6.1. Rest of Asia-Pacific Colon Cancer Diagnostic Tests Market by Test
6.4.3.6.2. Rest of Asia-Pacific Colon Cancer Diagnostic Tests Market by End User
6.4.4. Asia-Pacific Colon Cancer Diagnostic Tests Market by Test
6.4.5. Asia-Pacific Colon Cancer Diagnostic Tests Market by End User
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. LAMEA Colon Cancer Diagnostic Tests Market by Country
6.5.3.1. Brazil
6.5.3.1.1. Brazil Colon Cancer Diagnostic Tests Market by Test
6.5.3.1.2. Brazil Colon Cancer Diagnostic Tests Market by End User
6.5.3.2. Saudi Arabia
6.5.3.2.1. Saudi Arabia Colon Cancer Diagnostic Tests Market by Test
6.5.3.2.2. Saudi Arabia Colon Cancer Diagnostic Tests Market by End User
6.5.3.3. South Africa
6.5.3.3.1. South Africa Colon Cancer Diagnostic Tests Market by Test
6.5.3.3.2. South Africa Colon Cancer Diagnostic Tests Market by End User
6.5.3.4. Rest of LAMEA
6.5.3.4.1. Rest of LAMEA Colon Cancer Diagnostic Tests Market by Test
6.5.3.4.2. Rest of LAMEA Colon Cancer Diagnostic Tests Market by End User
6.5.4. LAMEA Colon Cancer Diagnostic Tests Market by Test
6.5.5. LAMEA Colon Cancer Diagnostic Tests Market by End User
CHAPTER 7 COMPANY PROFILES
7.1. QUIDEL CORPORATION
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. EIKEN CHEMICAL CO., LTD.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. EPIGENOMICS AG
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. BECKMAN COULTER, INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ABBOTT LABORATORIES
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. BIOHIT OYJ.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. POLYMEDCO CDP, LLC
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. QUEST DIAGNOSTICS INCORPORATED
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. RANDOX LABORATORIES LTD.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. EDP BIOTECH
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
